The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
07
No.
41
October 09, 1981
- Armand Hammer Panel chairman; DeVita Announces Greenwald Appointment; Adamson To Be DCCP Director
- In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival
- FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts
TCL
Vol.
07
No.
42
October 16, 1981
- NCI Facing Its Most Serious Fiscal Crisis With Order To Cut 1982 Budget 12 Percent; NCAB Objects To Reagan
- In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President
- DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP
- DCT Board Delays Action On Protein Index, Refuses Support for Cow Study, Approves Various Concepts
TCL
Vol.
07
No.
43
October 23, 1981
- Post Starts Series With Horror Stories On Drug Testing; DeVita Says They Are “Slanted, Distorted”
- In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level
- NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”
- NCAB Subcommittee Oks Concept Of Five Recompetitions
TCL
Vol.
07
No.
46
November 13, 1981
TCL
Vol.
07
No.
47
November 20, 1981
- CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round
- In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence
- Organ Site Program Fate On Line, Gets Review Next Week
- Hawking Hearings Turn Up Difference Between Management, Staff At FDA
- Scientists Defend NCI, Criticize Post Series As Inaccurate
TCL
Vol.
07
No.
48
November 27, 1981
- Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA
- In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says
- Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress
- Radiation Oncologist Objects To ACR Comments Results